Skip to main content
. 2021 Aug 19;11(3):20458940211037274. doi: 10.1177/20458940211037274

Fig. 4.

Fig. 4.

New therapeutic targets in PH.

SIN3a: switch-independent 3a; TET1: ten-eleven translocase methylcytosine dioxygenase 1; DNMT1: DNA methyltransferase 1; BMPR2: bone morphogenetic protein receptor type 2; PASMCs: pulmonary arterial smooth muscle cells; MCT: monocrotaline; NFU1: mitochondrial iron-sulfur scaffold; FA = fatty acid; ROS: reactive oxygen species; CHK1: checkpoint kinases 1; CHK2: checkpoint kinases 2; sGC β1: soluble guanylate cyclase β1 subunit; cGMP: cyclic 3′5′ guanosine monophosphate; SGLT2: sodium glucose co-transporter 2.